Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 20/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21750536 | 1.00 | RORC (0.62) | RORC | |
| SCHEMBL21750510 | 0.91 | RORC (0.62) | RORC | |
| SCHEMBL21750505 | 0.91 | RORC (0.62) | RORC | |
| SCHEMBL21750527 | 0.83 | RORC (0.68) | RORC | |
| SCHEMBL21750525 | 0.83 | RORC (0.68) | RORC | |
| SCHEMBL21750493 | 0.83 | RORC (0.61) | RORC | |
| SCHEMBL21750494 | 0.83 | RORC (0.61) | RORC | |
| SCHEMBL21750521 | 0.83 | RORC (0.64) | RORC | |
| SCHEMBL21750523 | 0.83 | RORC (0.64) | RORC | |
| SCHEMBL18477026 | 0.83 | RORC (0.64) | RORC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210300869-A1 | MODULATORS OF ROR-GAMMA | VITAE PHARMACEUTICAL, LLC | 2021-09-30 | — | — | US | claimed |
| US-20200062707-A1 | MODULATORS OF ROR-GAMMA | VITAE PHARMACEUTICALS, INC. | 2020-02-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200062707-A1 | MODULATORS OF ROR-GAMMA | RORB, RORC, RORA | RORC 2/4885 |
| US-20210300869-A1 | MODULATORS OF ROR-GAMMA | RORC, RORB, RORA | RORC 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.